Financials Etropal AD

Equities

ETR

BG1100001038

Medical Equipment, Supplies & Distribution

End-of-day quote Bulgaria S.E. 03:30:00 21/05/2024 am IST 5-day change 1st Jan Change
4.5 BGN +2.27% Intraday chart for Etropal AD +2.27% -2.17%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 28.75 29 28.75 28.75 31 23
Enterprise Value (EV) 1 33.58 34.23 33.86 32 35.9 27.08
P/E ratio 456 x 1,036 x 1,513 x -8.36 x -60.7 x -129 x
Yield - - - - - -
Capitalization / Revenue 3.47 x 4.26 x 3.79 x 2.45 x 4.6 x 2.05 x
EV / Revenue 4.05 x 5.02 x 4.47 x 2.73 x 5.32 x 2.42 x
EV / EBITDA 38.8 x 39.5 x 57.2 x -11.8 x 94.2 x 25.1 x
EV / FCF 105 x -76.9 x -27.1 x 24 x -62.2 x 30.7 x
FCF Yield 0.95% -1.3% -3.68% 4.16% -1.61% 3.26%
Price to Book 5.53 x 5.55 x 5.48 x 3.23 x 3.76 x 2.8 x
Nbr of stocks (in thousands) 5,000 5,000 5,000 5,000 5,000 5,000
Reference price 2 5.750 5.800 5.750 5.750 6.200 4.600
Announcement Date 17/04/19 27/04/20 26/02/21 12/04/22 24/04/23 22/04/24
1BGN in Million2BGN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 8.295 6.813 7.583 11.72 6.746 11.2
EBITDA 1 0.866 0.867 0.592 -2.702 0.381 1.079
EBIT 1 0.327 0.328 0.063 -3.263 -0.511 0.196
Operating Margin 3.94% 4.81% 0.83% -27.85% -7.57% 1.75%
Earnings before Tax (EBT) 1 0.073 0.038 0.021 -3.465 -0.783 -0.13
Net income 1 0.063 0.028 0.019 -3.44 -0.718 -0.028
Net margin 0.76% 0.41% 0.25% -29.36% -10.64% -0.25%
EPS 2 0.0126 0.005600 0.003800 -0.6880 -0.1022 -0.0356
Free Cash Flow 1 0.3189 -0.445 -1.247 1.332 -0.5771 0.8832
FCF margin 3.84% -6.53% -16.45% 11.37% -8.56% 7.89%
FCF Conversion (EBITDA) 36.82% - - - - 81.86%
FCF Conversion (Net income) 506.15% - - - - -
Dividend per Share - - - - - -
Announcement Date 17/04/19 27/04/20 26/02/21 12/04/22 24/04/23 22/04/24
1BGN in Million2BGN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 4.83 5.23 5.11 3.25 4.91 4.08
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 5.575 x 6.032 x 8.635 x -1.204 x 12.87 x 3.779 x
Free Cash Flow 1 0.32 -0.45 -1.25 1.33 -0.58 0.88
ROE (net income / shareholders' equity) 1.32% 0.68% 0.4% -47.8% -9.4% -1.5%
ROA (Net income/ Total Assets) 1.63% 1.53% 0.29% -13.5% -1.82% 0.67%
Assets 1 3.867 1.825 6.593 25.54 39.42 -4.173
Book Value Per Share 2 1.040 1.050 1.050 1.780 1.650 1.640
Cash Flow per Share 2 0.0300 0.0100 0.0200 0.0100 0.0100 0.0200
Capex 1 1.38 0.3 - 0.32 - -
Capex / Sales 16.67% 4.39% - 2.76% - -
Announcement Date 17/04/19 27/04/20 26/02/21 12/04/22 24/04/23 22/04/24
1BGN in Million2BGN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ETR Stock
  4. Financials Etropal AD